Merck & Co.
NYSE: MRK Healthcare Pharmaceuticals
$129.56
+— (+3.34%)
Merck & Co. is the 32nd largest stock tracked on DollarScout
by market cap
Market cap: $319.99B · Rank 32 of 60
Key stats
Market cap
$319.99B
Revenue (TTM)
—
Net income (TTM)
—
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Beta (5Y)
—
Shares outstanding
—
52W high
—
52W low
—
Day open
—
Previous close
—
Price chart
Healthcare peers
How MRK compares to other large companies in the same sector.
| Company | Price | Today | Market cap | P/E |
|---|---|---|---|---|
| LLY Eli Lilly and Company | $1213.91 | +1.86% | $1.08T | — |
| JNJ Johnson & Johnson | $263.04 | +3.57% | $633.19B | — |
| ABBV AbbVie Inc. | $261.07 | +3.99% | $461.26B | — |
| UNH UnitedHealth Group | $425.36 | -0.28% | $386.29B | — |
| PFE Pfizer Inc. | $24.32 | +1.84% | $138.61B | — |
Where to buy MRK
Open an account with a broker we've reviewed and start trading Merck & Co. today.
Robinhood
Commission-free · Best for beginners
Read review →
Webull
Advanced charts · For active traders
Read review →
Fidelity
Low fees · Best for retirement
Read review →
Want to practice first? Try the free Stock Trading Simulator with $100,000 virtual cash.
Disclaimer: The information on this page is provided for informational and educational purposes only and should not be considered financial, investment, or trading advice. DollarScout does not recommend buying or selling any specific security. Stock data may be delayed. Past performance is not indicative of future results. Always do your own research and consult a licensed financial advisor before making investment decisions.